General Information

HIV Nursing 2022 will take place virtually in September 2022. 

HIV Nursing 2022 will offer an opportunity for discussion, debate, and networking as nurses from around the world collectively work to improve the prevention, care, treatment, and support services delivered to people affected by HIV. Moreover, the conference will focus on the role of nurse clinical leadership in supporting global programmatic targets (95-95-95(-95)) and the Sustainable Development Goal of ending AIDS as a public health threat.

HIV Nursing 2022 will be sponsored by the International Association of Providers of AIDS Care (IAPAC) in partnership with the European HIV Nursing Network (EHNN), the National HIV Nursing Association (NHIVNA), and the Association of Nurses in AIDS Care (ANAC).

The conference Co-Chairs are Ian Hodgson, European HIV Nursing Network, London, England; Carole Treston, Association of Nurses in AIDS Care, Washington, DC, USA; Natasja van Holten, Dutch Society of HIV Nurses, Amsterdam, Netherlands; and Liz Foote, National HIV Nursing Association, London, England.

KEY DATES

Following are key dates relevant to registration, abstract submissions, and venue/accommodations:

  • Early Registration Deadline – May 27, 2022
  • Abstract Submission Deadline – June 17, 2022
  • Abstract Disposition Announcements – July 8, 2022
  • Standard Registration Deadline – July 22, 2022

Payment Schedule

Registration Type Early Registration
27 May 2022
Standard Registration
22 July 2022
Late Registration
Standard 160 EUR 180 EUR 200 EUR
Student 90 EUR 100 EUR 110 EUR

 

The HIV Nursing 2022 is made possible through an educational grant from Gilead Sciences and a commercial sponsorship from ViiV Healthcare.

Program

Since the beginning of the HIV epidemic, nurses have been on the front lines of care delivery. Nurses are ideally placed to promote and deliver high quality HIV prevention, care, and treatment that meets the needs of affected people and maximizes health outcomes for most at-risk individuals. HIV Nursing 2022 will provide nurses with evidence-based education on best practices and future directions in managing HIV and its comorbidities.

HIV Nursing 2022 will offer an opportunity for discussion, debate, and networking as nurses from around the world collectively work to improve the prevention, care, treatment, and support services delivered to people affected by HIV. Moreover, the conference will focus on the role of nurse clinical leadership in supporting global programmatic targets (95-95-95(-95)) and the Sustainable Development Goal of ending AIDS as a public health threat

Among the topics to be covered in plenaries or panel discussions at this year’s conference include:

  • Nurse Leadership in the Era of COVID-19
  • Innovations in HIV Nursing Treatment and Care
  • The Nurses’ Role in Generating Demand and Facilitating Uptake of PrEP
  • A Person-Centered Approach to Medical, Behavioral Health, and Social Needs
  • The Nurse-Delivered Cognitive Behavioral Intervention Model
  • Prioritizing Quality of Life for Aging Cohorts of People Living with HIV
  • The Role of Nurses in Advancing Human Rights and Social Justice

The conference will also feature four case study-based sessions covering mental health, social health, women’s health, and holistic health. In addition, the conference will include a professional development workshop for advanced practice nurses.

The HIV Nursing 2022 program will be forthcoming.

Register

Submit an Abstract

GENERAL GUIDELINES

Following are some general guidelines for individuals interested in submitting an abstract(s):

  • The abstract must NOT contain more than 300 words.
  • Acceptable abstracts shall contain a concise statement of the research, define the precise subject of the presentation, and be related to the main theme or a sub-theme of the conference.
  • Tables, figures, literature references, and acknowledgements should not form any part of the abstract’s content.
  • The author is responsible for all grammatical and factual details. You may edit your abstract after it has been submitted.
  • All abstracts must be submitted in English. If you are not fluent in English, please attempt to have your abstract reviewed by a fluent English speaker.
  • Define all abbreviations and concepts in your abstract at first use.
  • For therapeutic agents, only generic names may be used (trade names are not permitted).

ABSTRACT SUBMISSION AND ACCEPTANCE

Abstract submissions are encouraged in a wide variety of specific domains, including:

  • HIV Treatment
  • HIV Prevention
  • Key populations
  • Stigma/Discrimination

Within these areas we encourage coverage of:

  • Advances in basic science
  • Innovative monitoring strategies
  • Longitudinal or observational data
  • Innovations in modeling and biopsychosocial theory
  • Intervention development, implementation, and/or outcomes
  • Dissemination/implementation of evidence-based approaches
  • Operations research, demonstration projects, and practice-based approaches
  • Mental and spiritual health
  • Resource, structural, and service delivery issues and innovations
  • Implementation science design, evidence, and real-world applicability
  • Continuity of care in the context of COVID-19
  • Mitigation of HIV service disruption within the context of public health crises

The abstract submission deadline is 5:00 pm EDT, Friday, June 17, 2022. All abstracts must be submitted online, and all submissions will be acknowledged upon successful submission via the site. Faxed or mailed abstracts will not be considered.

Please record your abstract number. The number assigned to your abstract when it is submitted online will be the abstract number referenced throughout the conference, including in the Program and Abstracts book and during the Poster Session. A notice of acceptance or rejection will be sent via e-mail no later than July 8, 2022. The disposition of each abstract will be sent via e-mail only to the submitting author identified on the submission form for that abstract. That contact will be responsible for sharing the disposition with all other authors of the abstract (including the presenting author).

Accepted abstracts will be in one of two categories:

  1. Oral Abstract presentation
  2. Poster Abstract presentation

Presenting authors agree to register for and attend the conference as scheduled in either Oral Abstract sessions or the Poster Session. Oral abstract and poster presenters are responsible for their own travel and accommodation expenses, as well as the applicable registration fees.

Please note that only the abstracts of paid conference registrants will be included in the final conference Abstracts Book. Accepted abstracts will be published in the conference proceedings. Abstracts are considered official communication to IAPAC. Submission of an abstract implies permission to publish, and online posting, if accepted. A copy of any electronic presentation and handouts will be transferred to IAPAC.

Login or Register to submit an abstract


					

Our Conferences

Washington, DC

July 11 - 13, 2022

Register

Virtual

September 16 - 17, 2022

Register

Sevilla

October 11 - 13, 2022

Register

Virtual

October 2020 - March 2021

View Archives

Virtual

July 18 - 20, 2021

View Archives